Nanobiotix (NBTX) Invested Capital (2018 - 2025)

Nanobiotix's Invested Capital history runs 8 years deep, the most recent figure standing at $111.0 million for Q4 2025.

• On a quarterly basis, Invested Capital rose 103.99% year-over-year to $111.0 million in Q4 2025; TTM through Dec 2025 was $176.1 million, a 40.83% increase from a year earlier, with the FY2025 full-year figure at $107.7 million, up 97.99% from the prior year.
• Invested Capital grew to $111.0 million in Q4 2025 per NBTX's latest filing, from $5.4 million in the prior quarter.
• Across five years, Invested Capital topped out at $111.0 million in Q4 2025 and bottomed at $5.4 million in Q2 2025.
• The 5-year median for Invested Capital is $31.8 million (2023), against an average of $36.6 million.
• Across the five-year window, Invested Capital slumped 50.41% in 2024 and soared 103.99% in 2025, its largest moves.
• Year by year, Invested Capital stood at $52.6 million in 2021, then advanced by 3.04% to $54.2 million in 2022, then advanced by 0.29% to $54.4 million in 2023, then decreased by 0.02% to $54.4 million in 2024, then surged by 103.99% to $111.0 million in 2025.
• Per Business Quant, the three latest NBTX Invested Capital figures stand at $111.0 million (Q4 2025), $5.4 million (Q2 2025), and $54.4 million (Q4 2024).